Identification of potent virtual leads to design novel PLK1 inhibitors: pharmacophore modelling, virtual screening and molecular docking studies

By He Lufen   Zhou Lu   Wang Taijin   Li Zicheng   Tang Xiangyang  

Molecular Simulation, Vol. 39, Iss. 8, 2013-07 ,pp. : 640-652

Taylor & Francis Ltd

Access to resources Recommend Favorite

In silico Screening for Identification of Novel Anti-malarial Inhibitors by Molecular Docking, Pharmacophore Modeling and Virtual Screening

By  

Medicinal Chemistry, Vol. 11, Iss. 7, 2015-01 ,pp. : 687-700

Bentham Science Publishers

Access to resources Recommend Favorite

Pharmacophore‐based virtual screening, molecular docking, molecular dynamics simulation, and biological evaluation for the discovery of novel BRD4 inhibitors

By  

CHEMICAL BIOLOGY & DRUG DESIGN (ELECTRONIC), Vol. 91, Iss. 2, 2018-02 ,pp. : 478-490

John Wiley & Sons Inc

Access to resources Recommend Favorite

3D Pharmacophore-Based Virtual Screening and Docking Approaches toward the Discovery of Novel HPPD Inhibitors

By Fu Ying   Sun Yi-Na   Yi Ke-Han   Li Ming-Qiang   Cao Hai-Feng   Li Jia-Zhong   Ye Fei  

Molecules, Vol. 22, Iss. 6, 2017-06 ,pp. : 959-959

MDPI

Access to resources Recommend Favorite

Development of 3D-pharmacophore model followed by successive virtual screening, molecular docking and ADME studies for the design of potent CCR2 antagonists for inflammation-driven diseases

By Singh Rajesh   Balupuri Anand   Sobhia M. Elizabeth  

Molecular Simulation, Vol. 39, Iss. 1, 2013-01 ,pp. : 49-58

Taylor & Francis Ltd

Access to resources Recommend Favorite